BackHelix BioPharma Overview

Helix BioPharma Intangible Assets

Latest intangible assets for HBPCF: $18M.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$18.39M
↑ 0.00% YoYΔ $0.00 vs prior year quarter

Peer trimmed avg / median

Loading

Helix BioPharma Intangible Assets History

Loading

Helix BioPharma vs. peers: Intangible Assets Comparison

Loading

Helix BioPharma Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Helix BioPharma (HBPCF) FAQ

The latest intangible assets for HBPCF is $18M as of July 2026. That compares with $18M in the prior-year period — up 0.0% year over year. Investors often review this figure alongside Helix BioPharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, HBPCF's intangible assets moved from $18M to $18M — essentially flat versus a year earlier. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Helix BioPharma's operating scale or balance-sheet position.

A intangible assets figure of $18M for HBPCF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting HBPCF's intangible assets ($18M), review year-over-year change from $18M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Helix BioPharma's intangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.